Cargando…

Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times

Administration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause developmental fetal events, particularly if given during the first trimester of pregnancy. Therefore, use in pregnancy is not permitted. Howe ver,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sica, Antonello, Vitiello, Paola, Papa, Alfonso, Calogero, Armando, Sagnelli, Caterina, Casale, Danilo, Mottola, Maria, Svanera, Gino, Dodaro, Concetta Anna, Martinelli, Erika, Troiani, Teresa, Ciardiello, Fortunato, Casale, Beniamino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884922/ https://www.ncbi.nlm.nih.gov/pubmed/31844674 http://dx.doi.org/10.1515/med-2019-0087

Ejemplares similares

How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report
por: Sica, Antonello, et al.
Publicado: (2021)

Cancer- and Non-cancer Related Chronic Pain: From the Physiopathological Basics to Management
por: Sica, Antonello, et al.
Publicado: (2019)

Differential Diagnosis: Retroperitoneal Fibrosis and Oncological Diseases
por: Sica, Antonello, et al.
Publicado: (2019)

An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program
por: Sica, Antonello, et al.
Publicado: (2020)

Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training
por: Sica, Antonello, et al.
Publicado: (2020)

Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides
por: Vitiello, Paola, et al.
Publicado: (2023)

Primary Cutaneous DLBCL Non-GCB Type: Challenges of a Rare Case
por: Sica, Antonello, et al.
Publicado: (2020)

All-in-One Spinal Cord Stimulation in Lymphoproliferative Diseases
por: Sica, Antonello, et al.
Publicado: (2020)

Chronic Chest Pain Control after Trans-Thoracic Biopsy in Mediastinal Lymphomas
por: Sica, Antonello, et al.
Publicado: (2021)

Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Towards the era of precision medicine in metastatic colorectal cancer
por: Napolitano, Stefania, et al.
Publicado: (2020)

Gastroenterological complications in kidney transplant patients
por: Calogero, Armando, et al.
Publicado: (2020)

Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care
por: Martinelli, Erika, et al.
Publicado: (2007)

Does Physical Activity Regulate Prostate Carcinogenesis and Prostate Cancer Outcomes? A Narrative Review
por: Capece, Marco, et al.
Publicado: (2020)

Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa
por: Annibali, Ombretta, et al.
Publicado: (2015)

Biomarkers in NHL
por: Malek, Sami N.
Publicado: (2011)

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
por: de Vos, S, et al.
Publicado: (2018)

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
por: Graf, Solomon A., et al.
Publicado: (2022)

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study
por: Townsend, William, et al.
Publicado: (2023)

Rituximab monotherapy become an optimal treatment for primary pulmonary malt lymphoma
por: Alvarez-Sánchez, A.I., et al.
Publicado: (2018)

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)

Endoscopic Treatment and Pulmonary Rehabilitation for Management of Lung Abscess in Elderly Lymphoma Patients
por: Cascone, Roberto, et al.
Publicado: (2020)

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
por: Morgillo, Floriana, et al.
Publicado: (2011)

Epithelioid Hemangioma of the Nose: A Challenging Diagnosis
por: Schonauer, Fabrizio, et al.
Publicado: (2022)

Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature
por: Viscardi, Giuseppe, et al.
Publicado: (2019)

Primary Extra-Nodal DLBCL of Glands: Our Experiences outside Guidelines of Treatment
por: Sica, Antonello, et al.
Publicado: (2021)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
por: Sagnelli, Evangelista, et al.
Publicado: (2012)

Familial Polyposis Coli: The Management of Desmoid Tumor Bleeding
por: Calogero, Armando, et al.
Publicado: (2019)

Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
por: Martini, Giulia, et al.
Publicado: (2017)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941
por: Ciardiello, Davide, et al.
Publicado: (2022)

Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review
por: Longo, Nicola, et al.
Publicado: (2020)

Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case
por: Martinelli, Erika, et al.
Publicado: (2018)

Stem cell hunt in NHL
por: Merkel, Olaf, et al.
Publicado: (2015)

NHL - Extranodal T-cell lymphoma
por: Devi, Seema, et al.
Publicado: (2015)

Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy
por: Ackova, Darinka Gjorgieva, et al.
Publicado: (2016)

CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients
por: Napolitano, Stefania, et al.
Publicado: (2022)

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence
por: Troiani, Teresa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sc7inkcbm4tag80u2no85gpvjp